Human and translational immunology in the third millennium: progress, challenges and opportunities

Nat Immunol. 2019 Dec;20(12):1568-1573. doi: 10.1038/s41590-019-0543-6.

Abstract

Internationally renowned scientists gathered at the 2nd Human & Translational Immunology Conference in Kos, Greece, to discuss the latest advances in translational immunology, especially vaccinology, infectious diseases and tumor immunotherapy.

Publication types

  • Congress

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis
  • Antibodies, Monoclonal / therapeutic use
  • Antigens / chemistry
  • Antigens / genetics
  • Antigens / immunology
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / prevention & control*
  • Bacterial Vaccines / administration & dosage
  • Bacterial Vaccines / biosynthesis
  • Cancer Vaccines / administration & dosage
  • Cancer Vaccines / biosynthesis
  • Communicable Disease Control / methods*
  • Communicable Diseases / immunology
  • Communicable Diseases / pathology
  • Cytokines / agonists
  • Cytokines / antagonists & inhibitors
  • Cytokines / genetics
  • Cytokines / immunology
  • Fungal Vaccines / administration & dosage
  • Fungal Vaccines / biosynthesis
  • Humans
  • Hypersensitivity / immunology
  • Hypersensitivity / prevention & control*
  • Immunoassay / methods
  • Immunotherapy / methods*
  • Neoplasms / immunology
  • Neoplasms / prevention & control*
  • Translational Research, Biomedical / trends*
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / biosynthesis

Substances

  • Antibodies, Monoclonal
  • Antigens
  • Bacterial Vaccines
  • Cancer Vaccines
  • Cytokines
  • Fungal Vaccines
  • Viral Vaccines